Pre-existing arterial pathologic changes affecting arteriovenous fistula patency and cardiovascular mortality in hemodialysis patients.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
diabetes mellitus 1 endocrinologydiseases
hyperphosphatemia 1 endocrinologydiseases
vascular calcification 3 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.


Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
diabetes mellitus 1936 creation, the primary failure rate did not decrease [[8]]. This suggests that in addition to old age, diabetes mellitus (DM), and a small-diameter vessel, pre-existing arteriosclerotic changes at AVF anastomosis sites may
hyperphosphatemia 12486 patientsSeveral factors play a role in arterial micro-calcification (AMiC) in ESRD patients. Hypercalcemia, hyperphosphatemia , dyslipidemia, hypertension, DM, and uremic toxin induce vascular calcification [[41],[42]]. This leads
vascular calcification 12561 patients. Hypercalcemia, hyperphosphatemia, dyslipidemia, hypertension, DM, and uremic toxin induce vascular calcification [[41],[42]]. This leads to osteoblastic conversion of vascular smooth muscle cells [[43]]. The process
vascular calcification 12739 vascular smooth muscle cells [[43]]. The process is facilitated by decreased levels of inhibitors of vascular calcification such as fetuin A, matrix Gla protein, osteopontin, osteoprotegerin, and pyrophosphate. Along with uremic
vascular calcification 12968 toxin, oxidative stress and inflammation, which are commonly found in ESRD patients, are involved in vascular calcification [[41],[42]]. Shroff et al. [[44]] demonstrated that dialysis accelerates AMiC by triggering smooth muscle

You must be authorized to submit a review.